ZEGA Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.18M Buy
7,803
+147
+2% +$149K 0.81% 23
2025
Q4
$8.23M Buy
7,656
+1,048
+16% +$1M 0.97% 21
2025
Q3
$5.04M Buy
6,608
+132
+2% +$98.2K 0.67% 25
2025
Q2
$5.05M Buy
6,476
+4,764
+278% +$3.7M 0.69% 25
2025
Q1
$1.41M Sell
1,712
-6
-0.3% -$4.99K 0.22% 59
2024
Q4
$1.35M Buy
+1,718
New +$1.42M 0.34% 41

Other funds holding LLY

ZEGA Investments's LLY Position: Q1 2026 in Review

ZEGA Investments increased its Eli Lilly (LLY) stake by 1.9% in Q1 2026, buying an estimated $149K and bringing the position to 7,803 shares worth $7.18M. The position accounts for 0.81% of the portfolio, ranked #23.

ZEGA Investments first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.23M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • ZEGA Investments held 7,803 shares of Eli Lilly worth $7.18M as of Q1 2026.
  • ZEGA Investments bought 147 Eli Lilly shares in Q1 2026, an estimated $149K.
  • Eli Lilly made up 0.81% of ZEGA Investments's portfolio in Q1 2026, its #23 holding.
  • ZEGA Investments first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • ZEGA Investments's Eli Lilly position peaked at $8.23M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on ZEGA Investments's 13F filing for Q1 2026, filed 11 May 2026.